An assessment model for efficacy of autologous CD19 chimeric antigen receptor T-cell therapy and relapse or refractory diffuse large B-cell lymphoma risk - Bin Xue; Yifan Liu; Min Zhang; Gangfeng Xiao; Xiu Luo; Lili Zhou; Shiguang Ye; Yan Lu; Wenbin Qian; Li Wang; Ping Li; Aibin Liang; et al. (Chinese Medical Journal)